News in Brief

Vaccination updates: Cholera, influenza and meningococcal

CDC Advisory Committee releases the latest recommendations on immunization practices.

AOA Staff
Contact AOA Staff
Topics

The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) recently approved vaccination recommendations, including changes to vaccinations for this upcoming flu season.

Read the latest vaccine guidance from the CDC’s Advisory Committee on Immunization Practices, shared by Stanley E. Grogg, DO, the AOA’s liaison to the ACIP.

Cholera vaccine

This vaccination is recommended for adults ages 18-64 years who are traveling to an area of active cholera transmission.

Influenza vaccine

Due to concerns about poor effectiveness against influenza in the U.S. during the 2013-2014 and 2015-2016 seasons, ACIP makes the interim recommendation for the 2016-2017 season that live attenuated influenza vaccine should not be used.

Meningococcal vaccine

  • Children 2 years and older with HIV infection who have not been previously vaccinated should receive a two-dose primary series of the Meningococcal ACWY (MenACWY) vaccines.
  • Children ages 2 months through 2 years with HIV infection should receive an age-appropriate series of MenACWY.

      • If approved by the CDC’s director, the recommendations will be official when they are posted in the agency’s Morbidity and Mortality Weekly Report.